Efavirenz Metabolism and CNS Toxicity in Ugandan Children: CYP2B6 Genotype Impact
by Sandra Soeria-Atmadja·Updated 1mo ago
29.7 KB1files
Available on 1 platform
Sign in to view source links and access this dataset
Description
A 2015–2016 prospective study followed 99 ART-naïve Ugandan children aged 3–12 years, with plasma sampling at 2, 6, 12, and 24 weeks after initiating efavirenz-based therapy. Sandra Soeria-Atmadja authored this research quantifying efavirenz and its metabolites in plasma and exploring associations with CYP2B6 metabolizer phenotypes and CNS adverse effects. The dataset likely contains longitudinal measurements of drug and metabolite concentrations, genotype data, and questionnaire responses.
Use Cases
Modeling the relationship between CYP2B6 genotype and efavirenz metabolite ratios based on described plasma measurements.
Investigating associations between high efavirenz plasma concentrations (>4,000 ng/mL) and CNS symptoms based on the questionnaire data.
Studying the autoinduction of efavirenz metabolism over time in extensive metabolizers using the longitudinal sampling design.
Analyzing the distribution of conjugated versus unconjugated metabolite forms across different metabolizer phenotypes.
Strengths
Includes data from 99 pediatric patients, a specific and often understudied population.
Features longitudinal plasma sampling at four time points (2, 6, 12, and 24 weeks) to track changes.
Quantifies multiple efavirenz metabolites (8-OH-EFV, 7-OH-EFV, EFAdeg) in both conjugated and unconjugated forms.
Limitations
Row count and column-level documentation are unknown, which limits suitability assessment.
The dataset is small (29.7 KB), indicating limited scope, likely summary statistics or a supplementary document rather than raw patient-level data.
Data is specific to Ugandan children from 2015–2016; generalizability to other populations or time periods may be limited.
Provenance
Source
Sandra Soeria-Atmadja
Collection Method
Prospective clinical study using liquid chromatography high-resolution tandem mass spectrometry for quantification and genotyping for CYP2B6 and CYP2A6 SNPs.
Time Range
2015–2016
Freshness
Last updated 2026-04-24 05:40:35; freshness should be verified.
Geography
Uganda
Primary data file is a DOCX document (29.7 KB); the actual structured dataset may be embedded within or referenced by this document.